Want to see what weak discretionary spending looks like? See Winnebago’s results

Want to see what weak discretionary spending looks like? See Winnebago’s results


A Winnebago Industries Inc. travel trailer stands at Motor Sportsland RV dealership in Salt Lake City, Utah, U.S., on Monday, April 6, 2020.

George Frey | Bloomberg | Getty Images

Winnebago closed out its fiscal year with a solid fourth quarter earnings beat. Adjusted per-share profit of $1.59 easily topped Wall Street expectations thanks to the recreational-vehicle maker’s ability to efficiently manage costs, production and inventories in the quarter.

But that masked a big problem for the company – weaker discretionary spending. It’s a challenge across several sectors, from blue jeans to pizza delivery, as high inflation saps consumers.

The company on Wednesday also posted revenue of $771 million, a nearly 35% decline from a year ago. It fell short of Wall Street’s expected $784 million, as sales in its motorhome RV division significantly missed consensus views ($318 million vs. $355 million expected, according to StreetAccount).

Winnebago blamed “lower unit sales related to current market conditions and dealer efforts to reduce inventories, and higher discounts and allowances.” Unit deliveries of motorhome RVs plunged 52% year-over year.

Price increases weren’t nearly enough to overcome the weak demand.

CEO Michael Happe said “the consumer market continues to be challenged, and our fourth quarter results reflect a stubborn retail environment.”

While the company didn’t give financial guidance, Happe said he expects those trends to continue into the first half of the new fiscal year. By the second half of the fiscal year, though, Happe is optimistic that inventories will normalize and consumer demand will stabilize.

Winnebago’s stock, which was down 2% Wednesday, had fallen about 13% over the last three months, far underperforming the broader market. Rival Thor Industries had also fallen about 17% in that same timespan – a reflection of the challenging demand conditions across the industry.



Source

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi
Business

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi

Signage outside Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg | Getty Images Johnson & Johnson on Wednesday said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to rival best-selling shots. The FDA approved the pill, Icotyde, to treat […]

Read More
Macy’s store revamp shows progress, but company expects sales to fall this year
Business

Macy’s store revamp shows progress, but company expects sales to fall this year

Macy’s on Wednesday beat Wall Street’s quarterly sales and profit expectations as its namesake brand showed signs of progress, yet still gave a cautious outlook for the year ahead. For the fiscal year, the company – which includes its namesake chain, higher-end department store Bloomingdale’s and beauty retailer Bluemercury – said it expects sales of […]

Read More
Disney embarks on new chapter as Josh D’Amaro takes over as CEO
Business

Disney embarks on new chapter as Josh D’Amaro takes over as CEO

Larissa Manoela and Josh D’Amaro, Chairperson of Walt Disney Parks and Resorts, wave to the audience after Panel Disney Experiences during Day 2 of the D23 Brazil: A Disney Experience at Transamerica Expo Center on November 09, 2024 in Sao Paulo, Brazil. Ricardo Moreira | Getty Images Disney is turning the page on a new […]

Read More